Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Lymphoid 2 Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Other 1 Endocrine 1 Dermatologic 1

Conditions

Pain 1 Keratosis, Actinic 1 Agnosia 1

Interventions

Nivolumab 27 pembrolizumab 22 Ipilimumab 17 Temozolomide 13 toripalimab 12 Biopsy 10 Cyclophosphamide 9 Imiquimod 8 Dacarbazine 7 Blood Specimen Collection 7 camrelizumab 6 Chemotherapy, Adjuvant 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 aldesleukin 5 Gene Expression Profiling 5 Cisplatin 5 Aminolevulinic Acid 5 fludarabine phosphate 4 durvalumab 4 binimetinib 4 apatinib 4 Tomography, Optical Coherence 4 Sorafenib 4 Photochemotherapy 4 Interleukin-2 4 Injections 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Acetaminophen × Dermatologic × Clear all

NCT04779255 2021-09-29

ANTUKA

Poitiers University Hospital

Phase NA Unknown

Agnosia, Pain, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡